BioSpace News Archive

Lonza to Host New Webinar – “Cell Culture Media: Why Go Serum-Free?”

On 15 October, Lonza will host a free 60-minute webinar that will address current concerns regarding the use of serum in cell culture media, explore viable alternatives and provide guidance on how to adapt cells to a serum-free environment.

October 2, 2019
·
3 min read
Business

Entos Pharmaceuticals Announces Research, Development and Collaboration Agreement

Entos Pharmaceuticals Inc. announced it has entered into a research, development and collaboration agreement with a clinical stage biopharmaceutical company focused on the development of novel therapeutic compounds targeting autoimmune and inflammatory diseases.

October 2, 2019
·
2 min read
Policy

Information Update - Health Canada seized various unauthorized workout supplements, weight loss, and sexual enhancement products from “Atomik Nutrition” retailers and a warehouse in Québec

Health Canada is advising Canadians that the following products were seized because they may pose serious health risks.

October 2, 2019
·
5 min read
Business

Pharmacy Times Continuing Education™ Announces Keynote Speakers for Directions in Oncology Pharmacy™ Fall Conference Series

Drs. Emily Mackler and Evelyn Handel will give keynote speeches at the conferences

October 2, 2019
·
4 min read
BioCapital

Blue Cross and Blue Shield Federal Employee Program (FEP) Expands Benefits and Services in 2020

FEP Blue Focus(SM) moves into second year with no premium increase, while Standard and Basic Options introduce programs to help members live healthier lives

October 2, 2019
·
6 min read
BioCapital

NetNoggin® releases exploratory analysis “Alzheimer’s Recent Drug Failures”

NetNoggin® analyzes big data to better understand why Alzheimer’s drugs fail clinical trials and how the Alzheimer’s community reacts to the failures.

October 2, 2019
·
2 min read
Biotech Bay

Revance Earns Great Place to Work® Certification for Second Year

Revance Therapeutics, Inc. announced the company is certified as a great workplace by the independent analysts at Great Place to Work® for the second consecutive year.

October 2, 2019
·
5 min read
Drug Development

Janssen Submits Supplemental New Drug Application to U.S. FDA for SPRAVATO® (esketamine) CIII Nasal Spray for the Rapid Reduction of Depressive Symptoms in Adults with Major Depressive Disorder Who Have Active Suicidal Ideation with Intent

If approved, SPRAVATO® would be the first treatment for this severely ill population(1) who historically have been excluded from antidepressant clinical trials

October 2, 2019
·
19 min read
Pharm Country

The Rogosin Institute Launches Important Kidney Health Screening Program in New York City

The Rogosin Institute announced the launch of a new Kidney Health Screening program.

October 2, 2019
·
3 min read
Deals

Velan Comments on Announced Sale of Progenics to Lantheus

Believes Company’s Board has Abandoned its Fiduciary Duties by Choosing to Sell Progenics at Massive Discount in Attempt to Prevent the Voices of Shareholders from Being Heard

October 2, 2019
·
7 min read